| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 08/01/2002 | WO2002059600A2 Analyte detection |
| 08/01/2002 | WO2002059599A2 System and method for in vitro analysis of therapeutic agents |
| 08/01/2002 | WO2002059598A1 Method and apparatus for the precise positioning of cells and other small objects |
| 08/01/2002 | WO2002059597A1 Methods and devices for the electrically tight adhesion of a cell to a surface |
| 08/01/2002 | WO2002059596A2 Method and apparatus for measurement of the sulfate concentration in air samples |
| 08/01/2002 | WO2002059585A2 Oxygen monitoring apparatus and methods of using the apparatus |
| 08/01/2002 | WO2002059567A2 Lateral flow testing device with on-board chemical reactant |
| 08/01/2002 | WO2002059561A2 Modular computational models for predicting the pharmaceutical properties of chemical compounds |
| 08/01/2002 | WO2002059560A2 A method and system for predicting the biological activity, including toxicology and toxicity, of substances |
| 08/01/2002 | WO2002059559A2 Hydrocarbon sensor |
| 08/01/2002 | WO2002059558A2 Means and methods for treatment evaluation |
| 08/01/2002 | WO2002059377A2 Methods of diagnosis of breast cancer, compositions and methods of screening for modulators of breast cancer |
| 08/01/2002 | WO2002059376A1 Compositions, kits, and methods for identification, assessment, prevention, and therapy of human colon cancer |
| 08/01/2002 | WO2002059373A2 Genes overexpressed in prostate disorders as diagnostic and therapeutic targets |
| 08/01/2002 | WO2002059372A2 Three dimensional biochip |
| 08/01/2002 | WO2002059371A2 Genome-wide location and function of dna binding proteins |
| 08/01/2002 | WO2002059369A2 Compositions and methods for the treatment of diseases related to faulty cholesterol regulation |
| 08/01/2002 | WO2002059368A1 Specific mucin expression as a marker for pancreatic cancer |
| 08/01/2002 | WO2002059365A1 Method and apparatus for simultaneous quantification of different radionuclides on the surface of a biological microarray |
| 08/01/2002 | WO2002059363A2 Method for detecting of prions in a sample |
| 08/01/2002 | WO2002059361A1 Use of the slug gene or of the transcription or expression products thereof in the detection and/or treatment of cancerous cells |
| 08/01/2002 | WO2002059356A2 Method for screening compounds for activity in treating an osteoclast related bone disease |
| 08/01/2002 | WO2002059355A2 Polynucleotides for use as tags and tag complements, manufacture and use thereof |
| 08/01/2002 | WO2002059354A2 Polynucleotides for use as tags and tag complements, manufacture and use thereof |
| 08/01/2002 | WO2002059352A2 Methods and means for detecting enzymatic cleavage and linkage reactions |
| 08/01/2002 | WO2002059348A2 Methods for determining the genetic affinity of microorganisms and viruses |
| 08/01/2002 | WO2002059344A2 Gpr54 g protein-coupled receptor |
| 08/01/2002 | WO2002059327A2 Sulfatases and methods of use thereof |
| 08/01/2002 | WO2002059326A2 Isolated human phospholipase proteins, nucleic acid molecules encoding human phospholipase proteins, and uses thereof |
| 08/01/2002 | WO2002059323A2 Aminoacyl trna synthetases |
| 08/01/2002 | WO2002059321A2 Hepatitis c virus replicons and replicon enhanced cells |
| 08/01/2002 | WO2002059312A2 Cell adhesion proteins |
| 08/01/2002 | WO2002059311A2 Colon cancer marker |
| 08/01/2002 | WO2002059307A2 Human ltrpc7 proteins, nucleic acid molecules encoding them, and uses thereof |
| 08/01/2002 | WO2002059302A2 Regulation of human serotonin-like g protein-coupled receptor |
| 08/01/2002 | WO2002059299A2 Expression cloning method |
| 08/01/2002 | WO2002059286A2 Adenylate cyclases |
| 08/01/2002 | WO2002059285A1 Methods for immortalizing cells |
| 08/01/2002 | WO2002059283A2 Nucleic acid modification enzymes |
| 08/01/2002 | WO2002059280A2 Chronic lymphocytic leukemia cell line and its use for producing an antibody |
| 08/01/2002 | WO2002059267A2 Constitutively desensitized g protein-coupled receptors |
| 08/01/2002 | WO2002059262A2 Compositions and methods for detecting proteolytic activity |
| 08/01/2002 | WO2002059256A2 Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or virus resistance and their use as medicines |
| 08/01/2002 | WO2002059254A2 Method and device for detecting and controlling the level of biological contaminants in a coating process |
| 08/01/2002 | WO2002059154A2 Neutralizing human monoclonal antibodies against hiv-1, their production and uses |
| 08/01/2002 | WO2002059150A2 Materials and methods relating to protein aggregation in neurodegenerative disease |
| 08/01/2002 | WO2002059148A2 A method for identification, isolation and production of antigens to a specific pathogen |
| 08/01/2002 | WO2002059147A2 Activatable cytolytic or drug delivery peptides and uses thereof |
| 08/01/2002 | WO2002059144A2 Differential labeling for quantitative analysis of complex protein mixtures |
| 08/01/2002 | WO2002059142A2 Polymorphisms in the human gene for the multidrug resistance-associated protein 1 (mrp-1) and their use in diagnostic and therapeutic applications |
| 08/01/2002 | WO2002059140A2 Ikaros rgulatory elements and uses thereof |
| 08/01/2002 | WO2002058947A2 A method of wear testing a tire |
| 08/01/2002 | WO2002058845A2 Reaction vessel and system incorporating same |
| 08/01/2002 | WO2002058722A1 Method for diagnosing and treating dentinogenesis imperfecta type ii by using dentin sialophosphoprotein (dspp) gene and its encoding product |
| 08/01/2002 | WO2002058721A1 Trem-1 splice variant for use in modifying immune responses |
| 08/01/2002 | WO2002058719A1 Methods and compositions using cap43 proteins and nucleic acids to diagnose and treat cancer and other disorders |
| 08/01/2002 | WO2002058714A2 Methods and agents modulating upa/upar activity |
| 08/01/2002 | WO2002058709A1 Methods for inhibiting proliferation of astrocytes and astrocytic tumor cells and uses thereof |
| 08/01/2002 | WO2002058679A2 Antiangiogenic compounds and an assay for inhibitors of cell invasion |
| 08/01/2002 | WO2002058626A2 Methods and compositions for the identification and treatment of neurodegenerative disorders |
| 08/01/2002 | WO2002058623A2 Inhibitors of spermidine synthase for the treatment of osteoarthritis and cartilage rehabilitation |
| 08/01/2002 | WO2002058546A2 Methods for screening for substances which inhibit fp prostanoid receptor |
| 08/01/2002 | WO2002058534A2 Compositions and methods for the therapy and diagnosis of colon cancer |
| 08/01/2002 | WO2002058533A2 Process for determining target function and identifying drug leads |
| 08/01/2002 | WO2002058532A2 Method for identifying ligands to lxr-receptor that stimulates pre-adipocyte differentiation and formulations thereof |
| 08/01/2002 | WO2002058450A2 Regulation of cell growth by muc1 |
| 08/01/2002 | WO2002046730A8 System and method for measuring the dielectric strength of a fluid |
| 08/01/2002 | WO2002043864A3 Devices and methods for biochip multiplexing |
| 08/01/2002 | WO2002042737A3 Removal of embedding media from biological samples and cell conditioning on automated staining instruments |
| 08/01/2002 | WO2002042732A3 A method to measure the activation state of signaling pathways in cells |
| 08/01/2002 | WO2002036761A9 Compositions and methods for the diagnosis of cancer |
| 08/01/2002 | WO2002035987A3 METHODS FOR IDENTIFYING TREATMENTS FOR NEUROTOXICITY IN ALZHEIMER'S DISEASE CAUSED BY β-AMYLOID PEPTIDES |
| 08/01/2002 | WO2002033411A8 Improved ligand binding assays for vanilloid receptors |
| 08/01/2002 | WO2002029409A3 Method of assaying pyrrole-containing biological compounds |
| 08/01/2002 | WO2002029407A3 Dye-labelled peptide and its diagnostic use |
| 08/01/2002 | WO2002028841A3 Reagents for labeling biomolecules having aldehyde or ketone moieties |
| 08/01/2002 | WO2002027293A3 Gas or heat detector, gas or heat generator, flue gas generator, method for testing a gas detector or a heat detector, and method for testing a flue gas detector |
| 08/01/2002 | WO2002025286A3 Methods for the diagnosis of neoplastic disorders using angiogenin |
| 08/01/2002 | WO2002017963A3 Modulators of intermediate conductance calcium-activated potassium (ikca) channel activity for treating sexual dysfunction |
| 08/01/2002 | WO2002014475A3 Quantitative assessment of erbb/her receptors in biological fluids |
| 08/01/2002 | WO2002012855A3 Method and system for rapid biomolecular recognition of amino acids and protein sequencing |
| 08/01/2002 | WO2002012545A3 Method of identifying immunosuppressive agents |
| 08/01/2002 | WO2002010745A3 Cytological evaluation of breast duct epithelial cells retrieved by ductal lavage |
| 08/01/2002 | WO2002009573A3 Prognostic classification of endometrial cancer |
| 08/01/2002 | WO2002008734A3 Methods using light emission for determining the effectiveness of plant treatment agents in controlling plant disease organisms |
| 08/01/2002 | WO2002004509A3 Gene expression, genome alteration and reporter expression in myofibroblasts and myofibroblast-like cells |
| 08/01/2002 | WO2002003305A3 Method and apparatus for sequence analysis |
| 08/01/2002 | WO2002002764A3 High molecular weight derivatives of vitamin k-dependent polypeptides |
| 08/01/2002 | WO2002002625A3 Novel fibroblast growth factors and nucleic acids encoding same |
| 08/01/2002 | WO2002000928A3 Diagnosis of diseases associated with the immune system by determining cytosine methylation |
| 08/01/2002 | WO2001092560A3 Assay for kinases and phosphatases |
| 08/01/2002 | WO2001090163A3 Use of the gabab receptor in assays to identify gamma hydroxybutyrate agonists, antagonists, and allosteric modulators of agonists |
| 08/01/2002 | WO2001084132A3 Chemosensor and method for calibrating chemosensors |
| 08/01/2002 | WO2001080633A3 Surfactant protein d for the prevention and diagnosis of pulmonary emphysema |
| 08/01/2002 | WO2001072836A3 G-protein coupled receptors |
| 08/01/2002 | WO2001071354A3 Inorganic particle conjugates |
| 08/01/2002 | WO2001070979A9 Genes, compositions, kits, and method for identification, assessment, prevention and therapy of ovarian cancer |
| 08/01/2002 | WO2001070955A3 Identification of essential genes in prokaryotes |
| 08/01/2002 | WO2001065260A3 Diagnostic agent for chemotaxis |
| 08/01/2002 | WO2001059161A3 Analyte assays employing universal arrays |